Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
Clinical trial NCT05053802 · RECRUITING
Trial details
- NCT number
- NCT05053802
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-21
- Primary completion
- 2025-09-30
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.